|
|
Article: Business performance, investment returns lift China's pharma growth.
- Article from:
- China Business News
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 Gale acknowledges Publisher's copyright in the text of the Publication and shall place users of that text on notice of that copyright interest. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business performance, investment returns lift China's pharma growth
By Karl Zhong Shanghai. November 3. INTERFAX-CHINA - Strong business performance and high investment returns are two main factors accounting for net profit growth in Chinese pharmaceutical companies, according to recently- released third quarter financial results.
According to data from financial information provider Shanghai Wind Information Co. Ltd., 41 out of the 54 pharmaceutical companies listed on the Shanghai and Shenzhen Stock Exchanges, which disclosed performance results as of Oct. 27, reported net profit growth.
"Most Chinese pharmaceutical companies have performed ...